Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Axsome Thera (NQ: AXSM )

90.07 -0.63 (-0.69%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Axsome Thera

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
19 20 Next >
Why Is Axsome Therapeutics (AXSM) Stock Up 32% Today?
Axsome Therapeutics (AXSM) stock is soaring higher on Monday after releasing positive results from a Phase 3 clinical trial. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $13,000 Today
Via Benzinga
Stocks Stumbling After Thanksgiving Week
The Dow Jones Industrial Average is extending its premarket losses, down 265 points at midday, as protests in China over the country's zero-Covid policy weigh on investor sentiment globally. 
Via Talk Markets
Dow Tumbles Over 200 Points; Axsome Therapeutics Shares Spike Higher
U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 200 points on Monday. 
Via Benzinga
Is Axsome Therapeutics Stock a Buy Now?
The company seems to be coming into its own. 
Via The Motley Fool
Why Axsome Therapeutics Stock Is Bolting Higher Today
The biotech's promising Q3 earnings report has investors excited about the future. 
Via The Motley Fool
Axsome Therapeutics (AXSM) Q3 2022 Earnings Call Transcript
AXSM earnings call for the period ending September 30, 2022. 
Via The Motley Fool
US Stocks Start Week On Lower Note, Dow Drops Over 100 Points
U.S. stocks traded lower this morning, with the Dow Jones dropping more than 100 points on Monday. 
Via Benzinga
Axsome Therapeutics Unusual Options Activity
Someone with a lot of money to spend has taken a bullish stance on Axsome Therapeutics (NASDAQ:AXSM). And retail traders should know. We noticed this today when the big position showed up on publicly... 
Via Benzinga
Analyst Says Coinbase 'A Waste Of Time', Taylor Swift's Concert Fiasco Under DOJ Probe, Shopify Clocks Record Black Friday Sales: Top Stories Monday, Nov. 28
CNBC 
Via Benzinga
Biogen Dives On Reports Of Alzheimer's Death While Axsome Soars On Its Study Success
Biogen and Axsome stocks diverged Monday on news out of their Alzheimer's studies. 
Via Investor's Business Daily
Why Axsome Therapeutics Stock Is Soaring Today
Axsome Therapeutics Inc (NASDAQ: AXSM) shares are trading higher Monday morning after the company announced AXS-05 achieved its primary endpoint in the ACCORD Phase 3 trial in Alzheimer's disease... 
Via Benzinga
Recap: Axsome Therapeutics Q3 Earnings
Axsome Therapeutics (NASDAQ:AXSM) reported its Q3 earnings results on Monday, November 7, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Axsome Therapeutics Investigational Drug Lowers Risk Of Agitation Relapse In Alzheimer's Patients
Axsome Therapeutics Inc's (NASDAQ: AXSM) AXS-05 substantially and statistically significantly delayed the time to relapse and prevented relapse of agitation in patients with Alzheimer's disease,... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Axsome Therapeutics Announces AXS-05 Achieves Primary Endpoint in the ACCORD Phase 3 Trial in Alzheimer’s Disease Agitation
From Axsome Therapeutics, Inc.
Via GlobeNewswire
Want to Double Your Money? Buying These Stocks Could be a Genius Move
These stocks are undervalued considering their long-term growth potential. 
Via The Motley Fool
3 Growth Stocks to Buy That Could Skyrocket
The future looks promising for all three of these stocks. 
Via The Motley Fool
Prediction: This Growth Stock Could Double in 2023
The next year should be a busy one for this drugmaker. 
Via The Motley Fool
Axsome Therapeutics to Present at the 5th Annual Evercore ISI HealthCONx Conference
From Axsome Therapeutics, Inc.
Via GlobeNewswire
Got $500? 3 Growth Stocks to Buy That Could Double Your Money
Innovative products and services could keep these companies growing. 
Via The Motley Fool
These 3 Stocks Are Crushing the Market. Wall Street Thinks They Can Soar at Least 78% Higher.
The good times could keep on rolling for these big winners. 
Via The Motley Fool
Axsome Therapeutics to Present at the Guggenheim 4th Annual Immunology and Neurology Conference
From Axsome Therapeutics, Inc.
Via GlobeNewswire
DuPont, Expeditors International, Planet Fitness And Other Big Gainers From Tuesday
U.S. stocks closed higher on Tuesday, with the Dow Jones surging more than 300 points. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga
Why Axsome Therapeutics Stock Slipped Today
Investors traded out of the company following the latest earnings release, but only to a modest degree. 
Via The Motley Fool
Axsome Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
From Axsome Therapeutics, Inc.
Via GlobeNewswire
2 Healthcare Stocks Poised to Rocket Higher in the 4th Quarter
These two healthcare stocks could deliver market-crushing gains by year's end. 
Via The Motley Fool
3 Top Healthcare Stocks to Buy for November
Catalysts lie ahead for these promising stocks. 
Via The Motley Fool
Why Greenhill Shares Climbed Around 25%; Here Are 100 Biggest Movers From Yesterday
Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) shares jumped 242.8% to close at $105.72 on Thursday. The company announced a strategic plan to enter into the clean energy industry. 
Via Benzinga
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
19 20 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.